Northrop Grumman CORP /DE/ Form 4 insider transactions
NYSE
Northrop Grumman's Chief Financial Officer, John Greene, received grants of Restricted Performance Stock Rights and Restricted Stock Rights under the 2024 Long-Term Incentive Stock Plan.
NYSE
Robert J. Fleming, CVP and President of Space Systems at Northrop Grumman, reported new equity awards and common stock transactions for tax withholding.
NYSE
Northrop Grumman's CVP & President of Mission Systems, Roshan S. Roeder, reported significant equity transactions, including the settlement of performance-based awards and new restricted stock grants.
NYSE
Northrop Grumman Director Mark A. Welsh III sold 95 shares of common stock on February 2, 2026, through a pre-arranged 10b5-1 trading plan.
NYSE
Northrop Grumman's Chair, CEO, and President, Kathy J. Warden, sold 10,000 shares of common stock in early January 2026 under a pre-arranged 10b5-1 trading plan.
NYSE
Northrop Grumman Director Arvind Krishna reported a pre-planned acquisition of 64 common shares at $570.21, to be deferred into a stock unit account on December 31, 2025, under a Rule 10b5-1 plan.
NYSE
Northrop Grumman Director Marianne Catherine Brown deferred 81 shares of common stock into a stock unit account under the company's 2024 Long-Term Incentive Stock Plan.
NYSE
Roshan S. Roeder, CVP & Pres. Mission Systems at Northrop Grumman, sold 84 shares of common stock for $555.35 per share under a pre-arranged trading plan.
NYSE
Northrop Grumman's CVP & President of Mission Systems, Roshan S. Roeder, vested 328 Restricted Stock Rights and sold 159 shares to cover tax obligations.
NYSE
Northrop Grumman Director Mark A. Welsh III reported multiple sales of common stock totaling 97 shares on November 24, 2025, under a Rule 10b5-1 trading plan.
NYSE
Northrop Grumman Director Marianne Catherine Brown acquired 76 shares of common stock at $609.32 per share, increasing her beneficial ownership to 10,836 shares.
NYSE
Northrop Grumman Director Arvind Krishna acquired 59 shares of common stock at $609.32 per share, increasing his beneficial ownership to 2,184 shares.
NYSE
A Northrop Grumman executive sold 729 shares of common stock for $525 per share under a pre-arranged Rule 10b5-1 trading plan.
NYSE
A director at Northrop Grumman Corporation sold 33 shares of common stock on July 7, 2025, through a pre-established Rule 10b5-1 trading plan.
NYSE
Northrop Grumman Corporation Director Arvind Krishna acquired 73 shares of common stock through a deferred compensation plan, increasing his beneficial ownership to 2,116 shares.
NYSE
Northrop Grumman Director Marianne Catherine Brown has deferred 93 shares of common stock into a stock unit account under the company's 2024 Long-Term Incentive Stock Plan, effective June 30, 2025.
NYSE
Northrop Grumman's CVP and President of Space Systems, Robert J. Fleming, sold 3,500 shares of common stock for approximately $1.77 million on June 13, 2025, pursuant to a Rule 10b5-1 trading plan.
NYSE
Form 4: Northrop Grumman Executive Thomas Jones Reports Stock Sales and Gifts Under Pre-Arranged Plan
Northrop Grumman's CVP and President of Aeronautics Systems, Thomas H. Jones, reported the sale of 729 shares and the gift of 616 shares of common stock, both executed under a Rule 10b5-1 trading plan.
NYSE
Kathy J. Warden, Chair, CEO, and President of Northrop Grumman Corp, sold 11,250 shares of common stock in pre-planned transactions totaling approximately $5.67 million.
NYSE
A director at Northrop Grumman Corp, Mark A. Welsh III, has reported the sale of 33 shares of common stock on June 5, 2025, executed under a pre-established Rule 10b5-1 trading plan.
NYSE
A Northrop Grumman Corporation executive, Roshan S. Roeder, sold 991 shares of common stock for $490 per share on June 4, 2025, as part of a pre-established Rule 10b5-1 trading plan.
NYSE
A Northrop Grumman Corporation executive, Thomas H. Jones, sold 729 shares of common stock for $480 per share on May 30, 2025, as part of a pre-established Rule 10b5-1 trading plan.
NYSE
Director Ann M. Fudge acquired 385 shares of Northrop Grumman common stock through a deferred stock unit transaction under the company's Long-Term Incentive Stock Plan.
NYSE
Director Kimberly A. Ross acquired 385 shares of Northrop Grumman common stock through the company's Long-Term Incentive Stock Plan on May 21, 2025.
NYSE
Mark A. Welsh III, a director of Northrop Grumman, acquired 385 shares of common stock through the company's Long-Term Incentive Stock Plan.
NYSE
Director James S. Turley acquired 385 shares of Northrop Grumman common stock through a deferred transaction under the company's Long-Term Incentive Stock Plan.
NYSE
Director Thomas M. Schoewe reports acquisition of Northrop Grumman common stock through a deferred stock unit account.
NYSE
Director Gary Roughead acquired 385 shares of Northrop Grumman common stock at $473.90 per share under the company's Long-Term Incentive Stock Plan.
NYSE
Director Arvind Krishna acquired 385 shares of Northrop Grumman common stock at $473.90 per share under the company's Long-Term Incentive Stock Plan.
NYSE
Director Madeleine Kleiner acquired 385 shares of Northrop Grumman common stock at $473.90 per share under the company's Long-Term Incentive Stock Plan.